PURIDIFY WAS ACQUIRED BY GE HEALTHCARE, NOW CYTIVA IN 2017 Global demand for cheaper biotherapeutics drives the need for bioprocessing cost reduction, a significant proportion of which comes from chromatography reagents and their operation. • Puridify uses nanofibre technology to create purification solutions for biotherapeutic manufacturing. • Puridify's chromatography reagent, FibroSelect, reduces bioprocessing costs for manufacturers. • FibroSelect offers substantial productivity increase in purification whilst making minimal changes to current best practice. Please visit our website for more information: www.puridify.com
| Website | http://www.cytiva.com |
| Revenue | $5 million |
| Funding | $4.2 million |
| Employees | 7 (0 on RocketReach) |
| Founded | 2013 |
| Phone | +44 1438 906820 |
| Technologies |
JavaScript
,
HTML
,
PHP
+41 more
(view full list)
|
| Industry | Biotechnology, Pharmaceuticals, Healthcare |
| Keywords | Bioprocessing, Chromatography, Reagents, Biotherapeutics, Purification, Protein Purification, Cost Reduction, Downstream Processing, Biopharma, Manufacturing, Biotechnology, Pharmaceutical, Process Optimization, Quality Control, Drug Development, Separation, Single Use Systems, Filtration, Analytics |
| Competitors | Thermo Fisher Scientific, Regeneron, Merck Group, Agilent Technologies, Lonza, Waters Corporation, Sartorius, Beckman Coulter Diagnostics, GE HealthCare, Bio-Rad Magyarország Kft. +51 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541713 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular Puridify employee's phone or email?
The Puridify annual revenue was $5 million in 2026.
The NAICS codes for Puridify are [541713, 5417, 54171, 54, 541].
The SIC codes for Puridify are [873, 87].